Market Size
The structural heart imaging market size was valued at USD 19,995.6 mn in 2025, projected to reach USD 49,150.2 mn by 2033, growing at a CAGR of 12.4% during the forecast period (2026-2033).
Structural heart imaging (SHI) is a cardiology field that deals with valvular and non-valvular heart disease. SHI is a molecular imaging technology that is used to screen the heart. This method uses high-resolution cameras to capture images of the heart's inner structures, which aid in the proper diagnosis of the patient's condition. The two most popular imaging techniques that closely analyze heart structure to reveal narrowing or blockage of blood vessels are echocardiography and angiography (MRI, CT, etc.).
Market Scope
| Metrics | Details |
| Market CAGR | 12.4% |
| Segments Covered | By Imaging Modality, By Procedure Type, By Application, By End user, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Market Dynamics
Significant advances in structural heart interventions are expected to drive market growth.
Structural heart disease intervention is a game-changing breakthrough that has already displaced open surgery and enabled the treatment of a larger number of patients at a reduced cost. Significant progress has been made in structural cardiac interventions over the previous decade. The advancements in interventions and imaging are inextricably linked, from transcatheter aortic and pulmonic valve replacement to left atrial appendage occlusion procedures, percutaneous mitral repair techniques, and, more recently, transcatheter mitral valve replacement and tricuspid interventions. The commercial availability of 3-dimensional (3D) echocardiography, for instance, improved the efficiency, precision, and adaptability of the edge-to-edge repair technique. The collaboration of ultrasound and device firms continues to fuel breakthroughs in imaging that can then assist drive device innovation, thanks in part to imaging groups like the American Society of Echocardiography. Because of the imaging-intensive nature of all of these procedures, imagers must be familiar with a wide range of anatomical targets, modern imaging techniques, and the execution of numerous procedural interventions. Imagers have proven crucial to the field's continuous progress due to this information foundation. Thus, the market is expected to drive in the forecast period from the above statements.
Restraint:
Strict regulatory guidelines for equipment used in structural heart imaging, a lack of awareness regarding cardiac-specific structural imaging, and higher costs are some of the factors due to which the market is expected to hamper the market growth.
Segmentation Analysis
Angiogram segment is expected to hold the largest market share in the structural heart imaging market
The angiogram segment is expected to dominate in 2020. The segment's growth is benefited because demand for various imaging modalities is projected to rise as the need for diagnostic and effective imaging for detecting SHDs, particularly CHDs, grows. Moreover, Angiogram is further segmented into MRI and CT. In the anatomic and functional evaluation of cardiovascular disease, MRI is a critical diagnostic technique. 2D phase-contrast (2D-PC) MRI has been used in several procedures for blood flow quantification. Flow in four dimensions MRI is a volumetric acquisition that records the vector field of blood flow and anatomic pictures in a time-resolved manner. Compared to 2D-PC, it also makes acquisition easier and allows for a more precise and thorough hemodynamic assessment. With advancements in accelerated imaging, 4D flow MRI scanning times have been greatly reduced while image quality has been maintained, allowing this technology to move from research to everyday clinical practice. 4D flow MRI will likely become an essential component of cardiac imaging in practices dealing with congenital and acquired structural heart disease as experience grows, and 4D flow sequences and postprocessing software become more widely available.
Moreover, the use of advanced parallel imaging techniques like k-t GRAPPA has resulted in scan times that are more realistic, such as 8-12 minutes for 4D flow MRI of the aorta and 10-20 minutes for complete heart coverage. As a result, using 4D flow MRI in a clinical setting has become increasingly practicable, as seen by an increase in recent reports on the technique's utility in patient studies for measuring cardiac and vascular hemodynamics. Thus, the market is expected to hold the largest market share in the forecast period.
Key Developments
February 2026: Rising adoption of AI-enabled multimodality cardiac imaging platforms across North America and Europe enhanced diagnostic precision and procedural planning for structural heart interventions, including TAVR, TMVR, and LAAC procedures. Major companies, including GE HealthCare, Siemens Healthineers, and Philips Healthcare, accelerated the deployment of advanced echocardiography and cardiac CT solutions in tertiary cardiac centers.
January 2026: Increasing investments in hybrid catheterization laboratories and image-guided structural heart procedures across the United States, Germany, and Japan strengthened demand for real-time cardiac imaging technologies and advanced interventional visualization systems. Canon Medical Systems and Fujifilm Holdings Corporation expanded advanced cardiac imaging portfolios supporting minimally invasive cardiovascular interventions.
December 2025: The growing prevalence of structural heart diseases and aging populations across Europe and North America accelerated the adoption of advanced echocardiography, MRI, and cardiac CT imaging technologies in specialized cardiology centers. Abbott Laboratories and Boston Scientific Corporation strengthened collaborations focused on integrated imaging-guided cardiac intervention solutions.
November 2025: Expansion of AI-powered cardiac imaging software and automated valve assessment technologies improved procedural workflow efficiency and diagnostic reproducibility in structural heart imaging applications globally. GE HealthCare introduced advanced AI-enabled imaging solutions targeting enhanced clinical decision support and operational efficiency in cardiovascular diagnostics.
October 2025: Rising healthcare infrastructure modernization initiatives and increasing cardiovascular disease burden across Asia-Pacific regions, including China, India, and South Korea, strengthened deployment of advanced structural heart imaging systems in hospitals and specialty cardiac clinics. Samsung Medison and Mindray Medical International expanded regional cardiac imaging technologies supporting precision cardiology applications.
September 2025: Increasing strategic collaborations between imaging technology providers, healthcare institutions, and research organizations accelerated the development of AI-assisted cardiac CT analysis and next-generation 3D echocardiography platforms across Europe and North America. Siemens Healthineers expanded its AI-powered cardiovascular ultrasound and imaging portfolio to improve patient outcomes and diagnostic accuracy.
August 2025: Growing integration of multimodality imaging techniques, including CT, MRI, echocardiography, and catheter-based visualization, improved treatment planning and procedural safety for complex structural heart interventions globally. Cardiology experts across India and Europe highlighted the increasing adoption of AI-assisted imaging analysis and strain imaging technologies in advanced cardiac care.
July 2025: Rising adoption of transcatheter valve replacement and repair procedures across North America and Europe increased demand for high-resolution structural heart imaging systems and advanced visualization software. Medtronic plc, Edwards Lifesciences, and Terumo Corporation strengthened innovation in imaging-integrated cardiovascular intervention technologies.
June 2025: Increasing focus on precision cardiology, minimally invasive procedures, and outpatient cardiovascular treatment models accelerated global demand for compact and AI-enhanced structural heart imaging systems across ambulatory surgical centers and cardiac specialty clinics. North America maintained market leadership, while Asia-Pacific emerged as the fastest-growing regional market, driven by expanding healthcare investments and rising cardiac disease incidence.
Competitive Landscape
Major key players in the structural heart imaging market are
- Boston Scientific Corporation
- Circle Cardiovascular Imaging Inc
- Absolute Medical Services, Inc.
- Pie Medical Imaging B.V
- Siemens Healthineers GmbH
- Cardinal Health Inc
- Koninklijke Philips NV
- GE HealthCare
- Neusoft Medical Systems
Shimadzu Corporation
